PhD Candidate, University College London
Pierre Springuel is a PhD candidate in the Department of Biochemical Engineering at University College London. His research focuses on developing and optimizing scalable manufacturing processes to enable large-scale production of CAR-T cell therapies. He specializes in perfusion process intensification and scale-up in stirred-tank bioreactors, and in automating downstream processing.
Associate Director of Upstream Field Applications, Repligen Corporation
Earl Pineda is the associate director of upstream field applications at Repligen. Earl has been in the biotech industry for about 25 years, and has helped hundreds of companies successfully implement XCell® ATF technology globally over the past 14 years. He has worked at major biotech companies like Amgen, Novartis and Biomarin in process development, MSAT, and technology transfer.
Professor of Cell and Gene Therapy Bioprocess Engineering, Vice Dean (Health) in Faculty of Engineering at UCL
Dr. Qasim Rafiq is Vice Dean for Health in the Faculty of Engineering and a Professor in Bioprocess Engineering at University College London. He is a multidisciplinary engineer focusing on the bioprocessing, automation, and biomanufacturing of cell and gene-based therapies.
Product Manager, Immune Cell Media
Julia Hengst is Product Manager for Immune Cell Media at Sartorius. She joined the company as an External Collaborations Manager, where she built and led partnerships through scientific collaborations around immune and stem cell therapies.
She holds a PhD in immunology and has years of experience in product management for biomedical research and cell and gene therapy clinical applications.
